Different prognostic models for different patient populations: Validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe

British Journal of Cancer

Volumn 112, Issue 11, 2015, Pages 1733-1736

  Rietbergen, M M ^a   Witte, B I ^a   Velazquez, E R ^b   Snijders, P J F ^a   Bloemena, E ^a   Speel, E J ^c   Brakenhoff, R H ^a   Kremer, B ^c   Lambin, P ^b   Leemans, C R ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

human papillomavirus; oropharyngeal cancer; prognostic model validation

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMEDIATE RISK POPULATION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OROPHARYNX CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; SMOKING; VALIDATION STUDY; VERRUCA VULGARIS; WESTERN EUROPE; AGED; CARCINOMA, SQUAMOUS CELL; EUROPE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS TYPE 16; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PATHOGENICITY; PATHOLOGY; PROGNOSIS; SURVIVAL; VIROLOGY;

TUMOR MARKER;

AGED; CARCINOMA, SQUAMOUS CELL; EUROPE; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84930039932     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.139     Document Type: Article

References (15)

1. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML. (2010). Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1): 24-35
2. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML. (2011). Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32): 4294-4301
3. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. (2008). Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100(4): 261-269
4. Harrell Jr. FE, Lee KL, Mark DB. (1996). Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15(4): 361-387
5. Kallogjeri D, Piccirillo JF, Spitznagel Jr. EL, Steyerberg EW. (2012). Comparison of scoring methods for ACE-27: simpler is better. J Geriatr Oncol 3(3): 238-245
6. Kaplan MH, Feinstein AR. (1974). The importance of classifying initial co-morbidity in evaluatin the outcome of diabetes mellitus. J Chronic Dis 27(7-8): 387-404
7. Lambin P, Roelofs E, Reymen B, Velazquez ER, Buijsen J, Zegers CM, Carvalho S, Leijenaar RT, Nalbantov G, Oberije C, Scott MM, Hoebers F, Troost EG, van Stiphout RG, van EW, van der Weijden T, Boersma L, Valentini V, Dekker A (2013) 'Rapid Learning health care in oncology'-An approach towards decision support systems enabling customised radiotherapy'. Radiother Oncol 109(1): 159-164
8. Lambin P, van Stiphout RG, Starmans MH, Rios-Velazquez E, Nalbantov G, Aerts HJ, Roelofs E, van EW, Boutros PC, Granone P, Valentini V, Begg AC, De RD, Dekker A. (2013). Predicting outcomes in radiation oncology-multifactorial decision support systems. Nat Rev Clin Oncol 10(1): 27-40
9. O'Sullivan B, Huang SH, Siu LL, Waldron J, Zhao H, Perez-Ordonez B, Weinreb I, Kim J, Ringash J, Bayley A, Dawson LA, Hope A, Cho J, Irish J, Gilbert R, Gullane P, Hui A, Liu FF, Chen E, Xu W. (2013). Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 31(5): 543-550
10. Posner MR, Lorch JH, Goloubeva O, Tan M, Schumaker LM, Sarlis NJ, Haddad RI, Cullen KJ. (2011). Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol 22(5): 1071-1077
11. Rietbergen MM, Brakenhoff RH, Bloemena E, Witte BI, Snijders PJ, Heideman DA, Boon D, Koljenovic S, Baatenburg-de Jong RJ, Leemans CR. (2013). Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment de-escalation trials. Ann Oncol 24(11): 2740-2745
12. Rietbergen MM, Leemans CR, Bloemena E, Heideman DA, Braakhuis BJ, Hesselink AT, Witte BI, Baatenburg de Jong RJ, Meijer CJ, Snijders PJ, Brakenhoff RH. (2013). Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 132(7): 1565-1571
13. Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, Solomon B, Choi J, O'Sullivan B, Kenny LM, McArthur GA. (2010). Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 28(27): 4142-4148
14. Shaw R, Robinson M. (2011). The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer. Br J Oral Maxillofac Surg 49(6): 423-429
15. Smeets SJ, Hesselink AT, Speel EJ, Haesevoets A, Snijders PJ, Pawlita M, Meijer CJ, Braakhuis BJ, Leemans CR, Brakenhoff RH. (2007). A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121(11): 2465-2472